company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q1,2013-01-01,2013-03-31,2014-06-24 17:16:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q1,2013-01-01,2013-03-31,2014-06-24 17:16:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q1,2013-01-01,2013-03-31,2014-06-24 17:16:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q1,2013-01-01,2013-03-31,2014-06-24 17:16:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,22000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q1,2013-01-01,2013-03-31,2014-06-24 17:16:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6788000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q1,2013-01-01,2013-03-31,2014-06-24 17:16:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25408000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q1,2013-01-01,2013-03-31,2014-06-24 17:16:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32196000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q1,2013-01-01,2013-03-31,2014-06-24 17:16:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-32174000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q1,2013-01-01,2013-03-31,2014-06-24 17:16:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-32174000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q1,2013-01-01,2013-03-31,2014-06-24 17:16:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32174000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q1,2013-01-01,2013-03-31,2014-06-24 17:16:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32174000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q1,2013-01-01,2013-03-31,2014-06-24 17:16:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-32174000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 17:38:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 17:38:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 17:38:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 17:38:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 17:38:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8557000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 17:38:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30400000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 17:38:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38957000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 17:38:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-38952000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 17:38:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 17:38:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 17:38:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-38952000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 17:38:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 17:38:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-38952000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 17:38:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-38952000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 17:38:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-38952000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 17:38:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31700000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 17:38:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.23
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 17:38:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31700000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 17:38:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.23
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 17:38:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31768000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 17:38:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.23
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:13:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:13:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:13:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:13:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:13:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8801000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:13:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32301000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:13:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41102000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:13:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-41078000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:13:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:13:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-41078000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:13:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:13:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-41078000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:13:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-41078000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:13:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-41078000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:13:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31800000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:13:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.29
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:13:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31800000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:13:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.29
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:13:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31741000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 16:13:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.29
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,175000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,175000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,175000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11785000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32470000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,44255000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-44080000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-44080000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-44080000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-44080000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-44080000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31800000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.4
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31800000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.4
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31741000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.4
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,945000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,945000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,188000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,188000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,757000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,19052000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,41723000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,60775000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-60018000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-60018000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-60018000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-60018000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-60018000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31800000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.89
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31800000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.89
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31741000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.89
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,2014-08-13 17:38:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2974000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,2014-08-13 17:38:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2974000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,2014-08-13 17:38:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,279000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,2014-08-13 17:38:55+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,279000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,2014-08-13 17:38:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2695000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,2014-08-13 17:38:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13118000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,2014-08-13 17:38:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,46283000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,2014-08-13 17:38:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,59401000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,2014-08-13 17:38:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-56706000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,2014-08-13 17:38:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,2014-08-13 17:38:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,214000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,2014-08-13 17:38:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,214000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,2014-08-13 17:38:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-56492000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,2014-08-13 17:38:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1723000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,2014-08-13 17:38:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-58215000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,2014-08-13 17:38:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-58215000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,2014-08-13 17:38:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-58215000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,2014-08-13 17:38:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31800000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,2014-08-13 17:38:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.83
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,2014-08-13 17:38:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31800000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,2014-08-13 17:38:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.83
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,2014-08-13 17:38:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31768000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,2014-08-13 17:38:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.83
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 16:13:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6336000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 16:13:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6336000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 16:13:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,369000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 16:13:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,369000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 16:13:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5967000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 16:13:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17705000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 16:13:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,38324000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 16:13:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,56029000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 16:13:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-50062000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 16:13:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,668000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 16:13:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,668000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 16:13:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-49394000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 16:13:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5101000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 16:13:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-54495000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 16:13:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-54495000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 16:13:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-54495000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 16:13:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31700000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 16:13:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.72
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 16:13:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31700000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 16:13:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.72
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 16:13:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31754000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 16:13:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.72
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1433000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1433000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3222000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3222000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-1789000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,21772000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,42192000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,63964000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-65753000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,983000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,983000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-64770000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-460000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-64310000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-64310000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-64310000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31800000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.02
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31800000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.02
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31755000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.02
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20401000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20401000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,371000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,371000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20030000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,21748000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,36019000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,57767000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-37737000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,211000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,211000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-37526000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4948000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-42474000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-42474000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-42474000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32900000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.29
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32900000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.29
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32830000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.29
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 20:42:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7134000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 20:42:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7134000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 20:42:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,505000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 20:42:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,505000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 20:42:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6629000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 20:42:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,21545000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 20:42:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30377000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 20:42:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,51922000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 20:42:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-45293000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 20:42:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,204000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 20:42:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,204000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 20:42:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-45089000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 20:42:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2514000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 20:42:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-47603000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 20:42:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-47603000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 20:42:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-47603000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 20:42:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33500000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 20:42:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.42
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 20:42:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33500000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 20:42:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.42
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 20:42:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33532000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 20:42:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.42
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:40:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10698000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:40:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10698000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:40:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,581000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:40:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,581000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:40:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10117000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:40:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,22845000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:40:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30367000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:40:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,53212000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:40:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-43095000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:40:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,104000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:40:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,104000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:40:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-42991000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:40:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4323000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:40:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-47314000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:40:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-47314000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:40:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-47314000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:40:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33800000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:40:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.4
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:40:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33800000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:40:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.4
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:40:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33689000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 18:40:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.4
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3893000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3893000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3200000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3200000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,693000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,24065000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32402000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,56467000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-55774000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,112000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,112000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-55662000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-10834000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-44828000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-44828000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-44828000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34100000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.23
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34100000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.23
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34150000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.23
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18410000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18410000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,778000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,778000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17632000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,23596000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,35678000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,59274000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-41642000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,186000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,186000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-41456000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,694000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-42150000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-42150000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-42150000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38300000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.1
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38300000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.1
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38326000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.1
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:05:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5471000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:05:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5471000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:05:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,638000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:05:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,638000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:05:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4833000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:05:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20261000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:05:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32069000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:05:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,52330000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:05:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-47497000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:05:31+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:05:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,308000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:05:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,308000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:05:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-47189000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:05:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,36000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:05:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-47225000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:05:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-47225000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:05:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-47225000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:05:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44600000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:05:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.06
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:05:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44600000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:05:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.06
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:05:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44407000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:05:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.06
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 19:17:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19075000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 19:17:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19075000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 19:17:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,332000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 19:17:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,332000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 19:17:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18743000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 19:17:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20286000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 19:17:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,31951000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 19:17:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,52237000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 19:17:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-33494000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 19:17:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 19:17:11+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 19:17:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,344000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 19:17:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,344000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 19:17:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-33150000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 19:17:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,812000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 19:17:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33962000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 19:17:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33962000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 19:17:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-33962000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 19:17:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46500000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 19:17:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.73
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 19:17:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46500000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 19:17:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.73
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 19:17:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46470000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 19:17:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.73
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5692000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5692000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1146000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1146000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4546000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20366000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,42014000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,62380000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-57834000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1404000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,474000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-930000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-58764000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8568000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-67332000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-67332000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-67332000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44800000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.37
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44800000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.37
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44711000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.37
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3087000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3087000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,565000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,565000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2522000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20786000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,40565000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,61351000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-58829000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2137000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1030000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1107000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-59936000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5383000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-65319000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-65319000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-65319000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,51400000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.27
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,51400000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.27
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,51617000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.27
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 06:16:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3509000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 06:16:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3509000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 06:16:56+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1364000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 06:16:56+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1364000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 06:16:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2145000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 06:16:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,24339000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 06:16:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,42927000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 06:16:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,67266000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 06:16:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-65121000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 06:16:56+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2137000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 06:16:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1425000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 06:16:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-712000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 06:16:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-65833000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 06:16:56+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,454000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 06:16:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-66287000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 06:16:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-66287000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 06:16:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-66287000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 06:16:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52200000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 06:16:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.27
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 06:16:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52200000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 06:16:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.27
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 06:16:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,52255000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 06:16:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.27
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:52:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4275000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:52:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4275000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:52:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,985000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:52:22+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,985000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:52:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3290000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:52:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20944000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:52:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,39343000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:52:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,60287000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:52:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-56997000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:52:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2136000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:52:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-8000000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:52:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1124000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:52:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9012000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:52:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-66009000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:52:22+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,868000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:52:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-66877000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:52:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-66877000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:52:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-66877000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:52:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52700000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:52:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.27
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:52:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52700000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:52:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.27
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:52:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,52611000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:52:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.27
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4515000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4515000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3116000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3116000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1399000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,29523000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,51052000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,80575000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-79176000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2137000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,170000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1210000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-757000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-79933000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6989000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-86922000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-86922000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-86922000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,53703000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.64
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,53703000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.64
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,52352000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.64
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8319000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8319000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,826000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,826000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7493000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,24704000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,47765000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,72469000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-64976000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2137000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,686000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1484000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,33000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-64943000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,144000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-65087000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-65087000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-65087000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,53400000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.22
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,53400000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.22
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,53256000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.22
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:31:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23476000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:31:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23476000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:31:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,-1448000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:31:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,-1448000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:31:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24924000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:31:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,25007000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:31:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,48621000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:31:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,73628000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:31:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-48704000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:31:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2137000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:31:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1949000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:31:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1284000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:31:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1096000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:31:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-47608000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:31:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-6790000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:31:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-40818000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:31:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-40818000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:31:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-40818000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:31:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,53700000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:31:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.76
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:31:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,53700000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:31:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.76
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:31:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,53799000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:31:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.76
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 06:17:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12838000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 06:17:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12838000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 06:17:39+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,705000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 06:17:39+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,705000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 06:17:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12133000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 06:17:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,21890000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 06:17:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52693000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 06:17:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,74583000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 06:17:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-62450000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 06:17:39+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2137000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 06:17:39+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3119000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 06:17:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1376000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 06:17:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2358000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 06:17:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-60092000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 06:17:39+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-659000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 06:17:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-59433000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 06:17:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-59433000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 06:17:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-59433000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 06:17:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,54000000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 06:17:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.1
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 06:17:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,54000000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 06:17:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.1
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 06:17:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54248000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 06:17:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.1
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15737000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15737000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,632000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,632000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15105000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,25457000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52269000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,77726000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-62621000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4071000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5428000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,7822000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,9179000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-53442000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-3256000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-50186000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-50186000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-50186000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,55076000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.91
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55076000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.91
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,53969000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.91
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5338000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5338000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5338000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,25186000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,53818000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,79004000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-73666000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7858000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6229000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2795000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1166000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-72500000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,80000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-72580000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-72580000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-72580000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,55818000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.32
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55818000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.32
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54938000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.32
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:31:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,26150000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:31:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26150000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:31:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:31:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26150000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:31:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,22227000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:31:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,46399000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:31:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,68626000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:31:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-42476000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:31:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7901000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:31:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8366000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:31:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2374000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:31:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2839000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:31:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-39637000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:31:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,201000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:31:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-39838000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:31:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39838000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:31:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-39838000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:31:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,55300000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:31:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.72
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:31:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55300000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:31:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.72
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:31:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,55529000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:31:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.72
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 06:17:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12427000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 06:17:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12427000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 06:17:39+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 06:17:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12427000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 06:17:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,25622000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 06:17:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52006000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 06:17:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,77628000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 06:17:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-65201000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 06:17:39+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8068000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 06:17:39+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,7197000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 06:17:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2089000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 06:17:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1218000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 06:17:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-63983000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 06:17:39+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-5552000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 06:17:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-58431000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 06:17:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-58431000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 06:17:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-58431000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 06:17:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,55600000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 06:17:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.05
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 06:17:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55600000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 06:17:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.05
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 06:17:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,55858000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 06:17:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.05
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29499000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29499000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29499000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,33046000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,67025000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,100071000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-70572000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8035000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,11913000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1137000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,5015000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-65557000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,49000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-65606000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-65606000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-65606000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,56452000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.16
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,56452000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.16
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,55610000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.16
